Statement of Organization, Functions, and Delegations of Authority, 29519 [2019-13368]
Download as PDF
<![CDATA[
jbell on DSK3GLQ082PROD with NOTICES
Federal Register / Vol. 84, No. 121 / Monday, June 24, 2019 / Notices
following the instructions on the webbased form provided. Your comment—
including your name and your state—
will be placed on the public record of
this proceeding, including the https://
www.regulations.gov website. As a
matter of discretion, the Commission
tries to remove individuals’ home
contact information from comments
before placing them on the
regulations.gov site.
If you file your comment on paper,
write ‘‘Energy Labeling Rule Comment,
FTC File No. ll’’ on your comment
and on the envelope, and mail it to the
following address: Federal Trade
Commission, Office of the Secretary,
600 Pennsylvania Avenue NW, Suite
CC–5610 (Annex J), Washington, DC
20580, or deliver your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW,
5th Floor, Suite 5610 (Annex J),
Washington, DC 20024. If possible,
submit your paper comment to the
Commission by courier or overnight
service.
Because your comment will be placed
on the publicly accessible website at
www.regulations.gov, you are solely
responsible for making sure that your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include any sensitive personal
information, such as your or anyone
else’s Social Security number; date of
birth; driver’s license number or other
state identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
VerDate Sep<11>2014
16:50 Jun 21, 2019
Jkt 247001
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted publicly at
www.regulations.gov, we cannot redact
or remove your comment unless you
submit a confidentiality request that
meets the requirements for such
treatment under FTC Rule 4.9(c), and
the General Counsel grants that request.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before August 23, 2019. For information
on the Commission’s privacy policy,
including routine uses permitted by the
Privacy Act, see https://www.ftc.gov/
site-information/privacy-policy.
Heather Hippsley,
Deputy General Counsel.
[FR Doc. 2019–13383 Filed 6–21–19; 8:45 am]
BILLING CODE 6750–01–P
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 82 FR 42555, dated
September 8, 2017) is amended to
reflect the Order of Succession for the
Centers for Disease Control and
Prevention.
Section C–C, Order of Succession, is
hereby amended as follows:
Delete in its entirety Section C–C,
Order of Succession, and insert the
following:
During the absence or disability of the
Director, Centers for Disease Control
and Prevention (CDC), or in the event of
a vacancy in that office, the first official
listed below who is available shall act
as Director, except that during a
planned period of absence, the Director
may specify a different order of
succession:
Frm 00027
Fmt 4703
1. Principal Deputy Director
2. Chief Medical Officer
3. Deputy Director for Public Health
Service and Implementation
Science
4. Deputy Director for Infectious
Diseases
5. Director, Center for Preparedness and
Response
6. Director, National Institute for
Occupational Safety and Health
herri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–13368 Filed 6–21–19; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2019–0016, NIOSH–
325]
Mining Automation and Safety
Research Prioritization; Reopening of
Comment Period
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice and reopening of
comment period.
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
29519
Sfmt 4703
On March 18, 2019 the
National Institute for Occupational
Safety and Health (NIOSH) of the
Centers for Disease Control and
Prevention (CDC) published a notice in
the Federal Register announcing that
NIOSH had recently established a
research program to address the rapidly
expanding area of automation and
associated technologies in mining, and
that NIOSH was requesting information
to inform the prioritization of research
to be undertaken by The Institute’s
Mining Program. NIOSH is seeking
input on priority gaps in knowledge
regarding the safety and health
implications of humans working with
automated equipment and associated
technologies in mining, with an
emphasis on worker safety and health
research in which NIOSH has the
comparative advantage, and is unlikely
to be undertaken by other federal
agencies, academia, or the private
sector. Written comments were to be
received by May 17, 2019. In response
to a request from an interested party,
NIOSH is announcing the reopening of
the comment period.
SUMMARY:
E:\FR\FM\24JNN1.SGM
24JNN1
]]>Agencies
[Federal Register Volume 84, Number 121 (Monday, June 24, 2019)]
[Notices]
[Page 29519]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13368]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 82 FR 42555, dated September 8, 2017) is
amended to reflect the Order of Succession for the Centers for Disease
Control and Prevention.
Section C-C, Order of Succession, is hereby amended as follows:
Delete in its entirety Section C-C, Order of Succession, and insert
the following:
During the absence or disability of the Director, Centers for
Disease Control and Prevention (CDC), or in the event of a vacancy in
that office, the first official listed below who is available shall act
as Director, except that during a planned period of absence, the
Director may specify a different order of succession:
1. Principal Deputy Director
2. Chief Medical Officer
3. Deputy Director for Public Health Service and Implementation Science
4. Deputy Director for Infectious Diseases
5. Director, Center for Preparedness and Response
6. Director, National Institute for Occupational Safety and Health
herri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-13368 Filed 6-21-19; 8:45 am]
BILLING CODE 4160-18-P
